Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.
Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.
Novartis workers prepare the production of flu vaccines during a 2009 media tour of the then-new plant in Holly Springs. The fate of the 430,000-square-foot facility came into focus Monday after Australian pharmaceutical giant CSL Limited announced it will buy the plant as part of a $275 million acquisition of Novartis’s influenza business.

Novartis selling Holly Springs vaccine plant in $275M deal

October 28, 2014 11:32 AM

More Videos

  • Cary neighbors speak out against rezoning for Habitat housing

    Residents around the Trimble Avenue area in Cary ask the town's Planning and Rezoning Board to deny a rezoning request for a 2.6 acre lot saying the planned affordable housing does not fit in with the neighborhood's density or appearance.